PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries
DOI:
https://doi.org/10.2340/actadv.v103.6532Keywords:
health services research, psoriasis, quality of lifeAbstract
Enhanced treatment options for psoriasis and growing use of guidelines increased the potential to better quality of psoriasis care in Europe. The aim of the PsoBarrier EU study is to compare the quality and processes of psoriasis care in four European countries with different healthcare systems, based on validated quality indicators. This cross-sectional survey was conducted in dermatology centres in Denmark, Germany, Poland and Spain on 1,304 patients, using standardized patient and physician questionnaires. Measured by quality of psoriasis care indicators, patients in Poland had the most critical outcomes, such as the highest disease severity (Psoriasis Area and Severity Index; PASI) and lowest health-related quality of life (Dermatology Life Quality Index; DLQI). This indicates differences in psoriasis care, with Polish participants experiencing more severe psoriasis and its consequences. Differences in the healthcare systems, which create barriers to accessing treatments, could explain variations in quality of care.
Downloads
References
Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 2020; 369: m1590.
https://doi.org/10.1136/bmj.m1590 DOI: https://doi.org/10.1136/bmj.m1590
Ferreira BIRC, Da Abreu JLPC, Reis JPGD, Da Figueiredo AMC. Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation. J Clin Aesthet Dermatol 2016; 9: 36-43.
Singh S, Taylor C, Kornmehl H, Armstrong AW. Psoriasis and suicidality: a systematic review and meta-analysis. J Am Acad Dermatol 2017; 77: 425-440.e2.
https://doi.org/10.1016/j.jaad.2017.05.019 DOI: https://doi.org/10.1016/j.jaad.2017.05.019
Halioua B, Chelli C, Misery L, Taieb J, Taieb C. Sleep disorders and psoriasis: an update. Acta Derm Venereol 2022; 102: adv00699.
https://doi.org/10.2340/actadv.v102.1991 DOI: https://doi.org/10.2340/actadv.v102.1991
Augustin M, Radtke MA. Quality of life in psoriasis patients. Expert Rev Pharmacoecon Outcomes Res 2014; 14: 559-568.
https://doi.org/10.1586/14737167.2014.914437 DOI: https://doi.org/10.1586/14737167.2014.914437
Korte J de, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc 2004; 9: 140-147.
https://doi.org/10.1046/j.1087-0024.2003.09110.x DOI: https://doi.org/10.1046/j.1087-0024.2003.09110.x
Jungen D, Augustin M, Langenbruch A, Zander N, Reich K, Strömer K, et al. Cost-of-illness of psoriasis - results of a German cross-sectional study. J Eur Acad Dermatol Venereol 2018; 32: 174-180.
https://doi.org/10.1111/jdv.14543 DOI: https://doi.org/10.1111/jdv.14543
Mustonen A, Mattila K, Leino M, Koulu L, Tuominen R. Psoriasis causes significant economic burden to patients. Dermatol Ther (Heidelb) 2014; 4: 115-124.
https://doi.org/10.1007/s13555-014-0053-2 DOI: https://doi.org/10.1007/s13555-014-0053-2
Radtke MA, Reich K, Blome C, Kopp I, Rustenbach SJ, Schäfer I, et al. Evaluation of quality of care and guideline-compliant treatment in psoriasis. Development of a new system of quality indicators. Dermatology (Basel) 2009; 219: 54-58.
https://doi.org/10.1159/000218161 DOI: https://doi.org/10.1159/000218161
Nast A, Altenburg A, Augustin M, Boehncke W-H, Härle P, Klaus J, et al. Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm - Teil 1: Therapieziele und Therapieempfehlungen. J Dtsch Dermatol Ges 2021; 19: 934-951.
https://doi.org/10.1111/ddg.14508_g DOI: https://doi.org/10.1111/ddg.14508_g
Augustin M, Eissing L, Langenbruch A, Enk A, Luger T, Maaßen D, et al. The German National Program on Psoriasis Health Care 2005-2015: results and experiences. Arch Dermatol Res 2016; 308: 389-400.
https://doi.org/10.1007/s00403-016-1637-8 DOI: https://doi.org/10.1007/s00403-016-1637-8
Daudén E, Pujol RM, Sánchez-Carazo JL, Toribio J, Vanaclocha F, Puig L, et al. Demographic characteristics and health-related quality of life of patients with moderate-to-severe psoriasis: the VACAP study. Actas Dermosifiliogr 2013; 104: 807-814.
https://doi.org/10.1016/j.ad.2013.03.005 DOI: https://doi.org/10.1016/j.ad.2013.03.005
Tribó MJ, Turroja M, Castaño-Vinyals G, Bulbena A, Ros E, García-Martínez P, et al. Patients with moderate to severe psoriasis associate with higher risk of depression and anxiety symptoms: results of a multivariate study of 300 Spanish individuals with psoriasis. Acta Derm Venereol 2019; 99: 417-422.
https://doi.org/10.2340/00015555-3114 DOI: https://doi.org/10.2340/00015555-3114
Ruiz Genao DP, Carretero G, Rivera-Diaz R, Carrascosa JM, Sahuquillo-Torralba A, Herrera-Acosta E, et al. Differences in epidemiology, comorbidities and treatment choice between plaque psoriasis and pustular psoriasis: results from the BIOBADADERM registry. Br J Dermatol 2022; 187: 817-820.
https://doi.org/10.1111/bjd.21763 DOI: https://doi.org/10.1111/bjd.21763
Loft ND, Egeberg A, Rasmussen MK, Bryld LE, Gniadecki R, Dam TN, et al. Patient-reported outcomes during treatment in patients with moderate-to-severe psoriasis: a Danish nationwide study. Acta Derm Venereol 2019; 99: 1224-1230.
https://doi.org/10.2340/00015555-3331 DOI: https://doi.org/10.2340/00015555-3331
Purzycka-Bohdan D, Kisielnicka A, Zabłotna M, Nedoszytko B, Nowicki RJ, Reich A, et al. Chronic plaque psoriasis in Poland: disease severity, prevalence of comorbidities, and quality of life. J Clin Med 2022; 11: 1254.
https://doi.org/10.3390/jcm11051254 DOI: https://doi.org/10.3390/jcm11051254
Schwarz CW, Loft N, Rasmussen MK, Nissen CV, Dam TN, Ajgeiy KK, et al. Predictors of response to biologics in patients with moderate-to-severe psoriasis: a Danish nationwide cohort study. Acta Derm Venereol 2021; 101: adv00579.
https://doi.org/10.2340/actadv.v101.351 DOI: https://doi.org/10.2340/actadv.v101.351
OECD/European Observatory on Health Systems and Policies, editor. Denmark: Country Health Profile 2021, State of Health in the EU. Paris/Brussels: OECD Publishing; 2021.
OECD/European Observatory on Health Systems and Policies, editor. Germany: Country Health Profile 2021, State of Health in the EU. Paris/Brussels: OECD Publishing; 2021.
OECD/European Observatory on Health Systems and Policies, editor. Poland: Country Health Profile 2021, State of Health in the EU. Paris/Brussels: OECD Publishing; 2021.
OECD/European Observatory on Health Systems and Policies, editor. Spain: Country Health Profile 2021, State of Health in the EU. Paris/Brussels: OECD Publishing; 2021.
Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Csörgö Z, Boonen H, et al. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment and monitoring recommendations. J Eur Acad Dermatol Venereol 2020; 34: 2461-2498.
https://doi.org/10.1111/jdv.16915 DOI: https://doi.org/10.1111/jdv.16915
Danish Health Authority. National clinical guideline on psoriasis: quick guide; 2016 [cited 2023 May 10]. Available from: https://www.sst.dk/en/English/publications/2016/National-clinical-guideline-on-psoriasis.
Reich A, Adamski Z, Chodorowska G, Kaszuba A, Krasowska D, Lesiak A, et al. Psoriasis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. pd 2020; 107: 92-108.
https://doi.org/10.5114/dr.2020.95258 DOI: https://doi.org/10.5114/dr.2020.95258
Carrascosa JM, Puig L, Belinchón Romero I, Salgado-Boquete L, Del Alcázar E, Andrés Lencina JJ, et al. Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 1. "Conceptos y manejo general de la psoriasis con terapia biológica". Actas Dermosifiliogr 2022; 113: 261-277.
https://doi.org/10.1016/j.ad.2021.10.003 DOI: https://doi.org/10.1016/j.ad.2021.10.003
WHO. Global report on psoriasis. Geneva: World Health Organization; 2016.
Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
https://doi.org/10.1159/000250839 DOI: https://doi.org/10.1159/000250839
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
https://doi.org/10.1111/j.1365-2230.1994.tb01167.x DOI: https://doi.org/10.1111/j.1365-2230.1994.tb01167.x
Bundesärztekammer. Ergebnisse der Ärztestatistik zum 31.12.2020: Tabelle 3: Ärztinnen/Ärzte nach Bezeichnungen und Tätigkeitsarten. Available from: https://www.bundesaerztekammer.de/baek/ueber-uns/aerztestatistik/aerztestatistik-2020.
Naczelna Izba Lekarska. Central Register of Physicians [cited 2020 Mar 3]. Available from: https://nil.org.pl/uploaded_files/1583227918_zestawienie-nr-04.pdf.
Barber-Pérez P, González López-Valcárcel B. Informe Oferta-Necesidad de Especialistas Médicos 2021-2035: EcoSalud. Universidad de Las Palmas de Gran Canaria; 2022. Available from: https://www.sanidad.gob.es/areas/profesionesSanitarias/profesiones/necesidadEspecialistas/docs/2022Estudio_Oferta_Necesidad_Especialistas_Medicos_2021_2035V3.pd.f
Danish Health Data Agency. Arbejdsstyrken af sundhedsuddannede: Opgørelserne viser arbejdsstyrken af antal sundhedsuddannede fordelt på år, faggrupper, herkomst, speciale, alder og køn, uddannelsesland, brancher og sektorer, region (2000-2020); 2020. Available from: https://www.esundhed.dk/Emner/Beskaeftigede-i-sundhedsvaesnet/Arbejdsstyrken-af-sundhedsuddannede.
OECD. Health at a Glance 2019: OECD indicators. Paris: OECD; 2019.
Jankowiak B, Kowalewska B, Krajewska-Kułak E, Khvorik DF. Stigmatization and Quality of Life in Patients with Psoriasis. Dermatol Ther (Heidelb) 2020; 10: 285-296.
https://doi.org/10.1007/s13555-020-00363-1 DOI: https://doi.org/10.1007/s13555-020-00363-1
Sommer R, Topp J, Mrowietz U, Zander N, Augustin M. Perception and determinants of stigmatisation of people with psoriasis in the German population. J Eur Acad Dermatol Venereol 2020; 34: 2845-2855.
https://doi.org/10.1111/jdv.16436 DOI: https://doi.org/10.1111/jdv.16436
Qureshi AA, Awosika O, Baruffi F, Rengifo-Pardo M, Ehrlich A. Psychological therapies in management of psoriatic skin disease: a systematic review. Am J Clin Dermatol 2019; 20: 607-624.
https://doi.org/10.1007/s40257-019-00437-7 DOI: https://doi.org/10.1007/s40257-019-00437-7
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Anna Langenbruch, Nicole Mohr, Valerie Andrees, Ihno Kessens, Adam Reich, Magdalena Czarnecka-Operacz, Luis Puig, Esteban Dauden, Lars Iversen, Matthias Augustin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
